IMMODULON
LIVE

Serial Number

79104058

Owner

Immodulon Therapeutics Limited

Attorney

Lynn M. Jorda

Filing Date

Jul 29, 2011

Add to watchlist:

No watchlists yet
View on USPTO

IMMODULON Trademark

Serial Number: 79104058 • Registration: 4307168

IMMODULON is a trademark filed by Immodulon Therapeutics Limited on July 29, 2011. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Immodulon Therapeutics Limited (4 trademarks)

475 Salisbury House
London EC2M5QQ , GB

Entity Type: 99

Trademark Details

Filing Date

July 29, 2011

Registration Date

March 26, 2013

Published for Opposition

January 8, 2013

Cancellation Date

July 30, 2021

Goods & Services

Vaccines; immune modulators, namely, pharmaceutical preparations for treatment of immune system related diseases, disorders, and dysregulation; vitamins and vitamin preparations

Medical and therapeutic services, namely, treatment of patients with immuno disorders; medical, hygienic and beauty care for human beings; provision of medical information; advisory services relating to medical services, preparations and apparatus, namely, providing medical information, consultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of health, namely, providing an on-line computer database featuring information regarding health and nutrition

Scientific and technological services and research and design relating thereto, namely, research and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research services, namely, research relating to immune system related diseases and disorders; clinical research in the field of medical science, namely, medical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biological products, medical apparatus, devices and instruments, namely, pharmaceutical drug development services; supply of information in the area of laboratory technology, namely, providing technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portals, namely, providing scientific information regarding immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; scientific consultancy, namely, consulting services in the field of immunotherapy products, namely, pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; consultancy and research in the fields of science and technology, namely, research in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic services, namely, laboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technology, namely, providing an on-line computer database in the field of medical and scientific research of immune dysregulation

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 19, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Feb 19, 2022 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Aug 29, 2020 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 4, 2020 INTS
INVALIDATION PROCESSED
Aug 4, 2020 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 1, 2020 INTR
CANCELLED SECTION 71
Nov 1, 2019 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 26, 2018 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jan 30, 2015 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 14, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 27, 2013 FICS
FINAL DISPOSITION PROCESSED
Jun 27, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 26, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 26, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Jan 14, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 8, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jan 8, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 19, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 19, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 19, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 4, 2012 PREV
ASSIGNED TO LIE
Dec 4, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2012 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 20, 2012 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 27, 2012 GNFN
FINAL REFUSAL E-MAILED
Jun 27, 2012 GNFR
FINAL REFUSAL WRITTEN
Jun 27, 2012 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2012 TROA
REFUSAL PROCESSED BY IB
Dec 19, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 30, 2011 RFCS
REFUSAL PROCESSED BY MPU
Nov 30, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 30, 2011 RFCR
NON-FINAL ACTION WRITTEN
Nov 29, 2011 CNRT
ASSIGNED TO EXAMINER
Nov 21, 2011 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 12, 2011 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 3, 2011 REPR